Long-term efficacy and safety of osilodrostat in patients with Cushing’s disease: results from the LINC 4 study extension

By sjmartinez • September 8, 2023

Gadelha M, Snyder PJ, Witek P, Bex M, Belaya Z, Turcu AF, Feelders RA, Heaney AP, Paul M, Pedroncelli AM, Auchus RJ. Long-term efficacy and safety of osilodrostat in patients with Cushing's disease: results from the LINC 4 study extension. Front Endocrinol (Lausanne). 2023 Aug 23;14:1236465. doi: 10.3389/fendo.2023.1236465. PMID: 37680892; PMCID: PMC10482037.

Tags: 11β-hydroxylase, Cushing’s disease, Digestive Diseases, hypercortisolism, long-term treatment, osilodrostat, Publications

A Practical Approach to the Diagnosis and Management of Hepatic Encephalopathy

Reau N, Bernstein D, Kwo P, Loftus M, Moore A, Saab S. A Practical Approach to the Diagnosis and Management of Hepatic Encephalopathy. Am J[...]

The impact of frailty on liver transplant candidacy – A survey study on current clinical practices in the United States

Thuluvath AJ, Buckholz A, Patel A, Verna EC, Duarte-Rojo A. The impact of frailty on liver transplant candidacy - A survey study on current clinical[...]

Reply to Letter on “Sex-Specific Trends and Demographic vs Epidemiologic Drivers of Alcohol-Related Cirrhosis in the U.S., 2021-2040”

Danpanichkul P, Diaz LA, Arab JP, Singal AG, Yang JD. Reply to Letter on "Sex-Specific Trends and Demographic vs Epidemiologic Drivers of Alcohol-Related Cirrhosis in[...]